June 7, 2017
Chris Boshoff, SVP, Immuno-Oncology, Translational and Early Development, in Chicago Interview on June 3 On the back of its diverse and broad portfolio, Pfizer Inc. is looking to tap its unique position to deliver its cancer medicines to as many...read more